Exact Sciences EPS - Earnings per Share 2010-2024 | EXAS

Exact Sciences annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Exact Sciences EPS for the quarter ending June 30, 2024 was $-0.09, a 80% decline year-over-year.
  • Exact Sciences EPS for the twelve months ending June 30, 2024 was $-0.95, a 60.91% decline year-over-year.
  • Exact Sciences 2023 annual EPS was $-1.13, a 68.08% decline from 2022.
  • Exact Sciences 2022 annual EPS was $-3.54, a 1.72% increase from 2021.
  • Exact Sciences 2021 annual EPS was $-3.48, a 36.15% decline from 2020.
Exact Sciences Annual EPS
2023 $-1.13
2022 $-3.54
2021 $-3.48
2020 $-5.45
2019 $-1.62
2018 $-1.43
2017 $-0.99
2016 $-1.63
2015 $-1.71
2014 $-1.25
2013 $-0.69
2012 $-0.88
2011 $-0.54
2010 $-0.29
2009 $-0.28
Exact Sciences Quarterly EPS
2024-06-30 $-0.09
2024-03-31 $-0.60
2023-12-31 $-0.26
2023-09-30 $0.00
2023-06-30 $-0.45
2023-03-31 $-0.42
2022-12-31 $-0.72
2022-09-30 $-0.84
2022-06-30 $-0.94
2022-03-31 $-1.04
2021-12-31 $-1.30
2021-09-30 $-0.97
2021-06-30 $-1.03
2021-03-31 $-0.18
2020-12-31 $-2.74
2020-09-30 $-1.35
2020-06-30 $-0.45
2020-03-31 $-0.91
2019-12-31 $-0.35
2019-09-30 $-0.31
2019-06-30 $-0.30
2019-03-31 $-0.66
2018-12-31 $-0.43
2018-09-30 $-0.37
2018-06-30 $-0.30
2018-03-31 $-0.33
2017-12-31 $-0.17
2017-09-30 $-0.23
2017-06-30 $-0.27
2017-03-31 $-0.32
2016-12-31 $-0.32
2016-09-30 $-0.36
2016-06-30 $-0.46
2016-03-31 $-0.49
2015-12-31 $-0.42
2015-09-30 $-0.45
2015-06-30 $-0.44
2015-03-31 $-0.40
2014-12-31 $-0.39
2014-09-30 $-0.39
2014-06-30 $-0.24
2014-03-31 $-0.23
2013-12-31 $-0.17
2013-09-30 $-0.16
2013-06-30 $-0.19
2013-03-31 $-0.17
2012-12-31 $-0.22
2012-09-30 $-0.21
2012-06-30 $-0.26
2012-03-31 $-0.19
2011-12-31 $-0.18
2011-09-30 $-0.15
2011-06-30 $-0.13
2011-03-31 $-0.08
2010-12-31 $-0.09
2010-09-30 $-0.08
2010-06-30 $-0.06
2010-03-31 $-0.06
2009-12-31 $-0.04
2009-09-30 $-0.03
2009-06-30 $-0.08
2009-03-31 $-0.13
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.361B $2.500B
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. The company is currently working on the development of additional tests for other types of cancer, with the goal of becoming a leader in cancer screening and diagnostics. Exact Sciences currently has two of the brands in cancer diagnostics, Cologuard and Oncotype DX. Cologuard Test: This is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Oncotype DX: Genomic Health's first product, the 21-gene Oncotype DX breast cancer test is used to predict the likelihood of cancer recurrence, patient survival within 10 years of diagnosis and chemotherapy benefit for early-stage patients.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $171.800B 17.19
Vertex Pharmaceuticals (VRTX) United States $119.279B 0.00
Regeneron Pharmaceuticals (REGN) United States $114.674B 27.08
Bristol Myers Squibb (BMY) United States $108.993B 39.24
Gilead Sciences (GILD) United States $105.501B 18.03
CSL (CSLLY) Australia $96.028B 0.00
GSK (GSK) United Kingdom $81.761B 9.48
Alnylam Pharmaceuticals (ALNY) United States $34.862B 0.00
Argenex SE (ARGX) Netherlands $32.888B 0.00
BioNTech SE (BNTX) Germany $28.294B 0.00
Biogen (BIIB) United States $27.492B 11.61
Moderna (MRNA) United States $24.278B 0.00
BeiGene (BGNE) Cayman Islands $22.712B 0.00
Illumina (ILMN) United States $22.146B 151.11
Genmab (GMAB) Denmark $15.675B 19.58
BioMarin Pharmaceutical (BMRN) United States $13.227B 39.13
Incyte (INCY) United States $13.025B 845.38
Vaxcyte (PCVX) United States $12.751B 0.00
Insmed (INSM) United States $12.548B 0.00
Bio-Techne Corp (TECH) United States $12.284B 48.09
Sarepta Therapeutics (SRPT) United States $11.684B 266.35
QIAGEN (QGEN) Netherlands $10.121B 21.37
Bio-Rad Laboratories (BIO.B) United States $9.106B 30.17
Legend Biotech (LEGN) United States $8.875B 0.00
Ascendis Pharma (ASND) Denmark $8.522B 0.00
Roivant Sciences (ROIV) United Kingdom $8.342B 0.00
Repligen (RGEN) United States $8.022B 122.42
Revolution Medicines (RVMD) United States $7.680B 0.00
Intra-Cellular Therapies (ITCI) United States $7.674B 0.00
Exelixis (EXEL) United States $7.559B 23.25
Halozyme Therapeutics (HALO) United States $7.368B 19.39
Viking Therapeutics (VKTX) United States $7.167B 0.00
Nuvalent (NUVL) United States $6.710B 0.00
Cytokinetics (CYTK) United States $6.190B 0.00
Zealand Pharma (ZLDPF) Denmark $6.187B 0.00
Blueprint Medicines (BPMC) United States $5.749B 0.00
Avidity Biosciences (RNA) United States $5.174B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.120B 0.00
Krystal Biotech (KRYS) United States $5.096B 341.11
Alkermes (ALKS) Ireland $4.775B 16.76
ADMA Biologics Inc (ADMA) United States $4.545B 75.00
Biohaven (BHVN) United States $4.537B 0.00
Axsome Therapeutics (AXSM) United States $4.429B 0.00
Immunovant (IMVT) United States $4.321B 0.00
Denali Therapeutics (DNLI) United States $4.156B 0.00
Arcellx (ACLX) United States $4.098B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.887B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.629B 0.00
Apellis Pharmaceuticals (APLS) United States $3.468B 0.00
Merus (MRUS) Netherlands $3.449B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.310B 0.00
Amicus Therapeutics (FOLD) United States $3.141B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.118B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.094B 0.00
Kymera Therapeutics (KYMR) United States $2.779B 0.00
Guardant Health (GH) United States $2.751B 0.00
Iovance Biotherapeutics (IOVA) United States $2.731B 0.00
IDEAYA Biosciences (IDYA) United States $2.678B 0.00
Geron (GERN) United States $2.676B 0.00
Protagonist Therapeutics (PTGX) United States $2.650B 17.17
Bavarian Nordic (BVNRY) Denmark $2.648B 14.30
Edgewise Therapeutics (EWTX) United States $2.556B 0.00
Zai Lab (ZLAB) China $2.551B 0.00
Twist Bioscience (TWST) United States $2.536B 0.00
Apogee Therapeutics (APGE) United States $2.530B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.510B 84.06
Structure Therapeutics (GPCR) United States $2.487B 0.00
ImmunityBio (IBRX) United States $2.487B 0.00
Myriad Genetics (MYGN) United States $2.449B 0.00
CG Oncology (CGON) United States $2.442B 0.00
SpringWorks Therapeutics (SWTX) United States $2.438B 0.00
Novavax (NVAX) United States $2.350B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.332B 0.00
Keros Therapeutics (KROS) United States $2.300B 0.00
Vera Therapeutics (VERA) United States $2.289B 0.00
Janux Therapeutics (JANX) United States $2.267B 0.00
Neumora Therapeutics (NMRA) United States $2.236B 0.00
Akero Therapeutics (AKRO) United States $2.028B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.022B 18.24
Celldex Therapeutics (CLDX) United States $2.003B 0.00
Vericel (VCEL) United States $1.996B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.979B 0.00
Beam Therapeutics (BEAM) United States $1.937B 0.00
Intellia Therapeutics (NTLA) United States $1.884B 0.00
Galapagos (GLPG) Belgium $1.870B 0.00
NeoGenomics (NEO) United States $1.838B 0.00
Certara (CERT) United States $1.829B 59.84
Ligand Pharmaceuticals (LGND) United States $1.826B 31.04
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.748B 0.00
MannKind (MNKD) United States $1.730B 62.90
Fortrea Holdings (FTRE) United States $1.716B 53.19
Arvinas (ARVN) United States $1.696B 0.00
NovoCure (NVCR) Jersey $1.677B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.654B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.555B 0.00
Viridian Therapeutics (VRDN) United States $1.549B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.544B 0.00
Disc Medicine (IRON) United States $1.522B 0.00
Belite Bio (BLTE) United States $1.491B 0.00
Dynavax Technologies (DVAX) United States $1.487B 103.18
Kura Oncology (KURA) United States $1.418B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.417B 0.00
Nurix Therapeutics (NRIX) United States $1.415B 0.00
Spyre Therapeutics (SYRE) United States $1.409B 0.00
Arcus Biosciences (RCUS) United States $1.407B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.246B 0.00
ANI Pharmaceuticals (ANIP) United States $1.210B 16.43
Bicara Therapeutics (BCAX) $1.201B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.196B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.195B 0.00
Tyra Biosciences (TYRA) United States $1.182B 0.00
Cogent Biosciences (COGT) United States $1.173B 0.00
Gyre Therapeutics (GYRE) United States $1.103B 0.00
WAVE Life Sciences (WVE) Singapore $1.101B 0.00
Praxis Precision Medicines (PRAX) United States $1.086B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.072B 0.00
Travere Therapeutics (TVTX) United States $1.061B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.056B 0.00
Vir Biotechnology (VIR) United States $1.049B 0.00
Mesoblast (MESO) Australia $1.000B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.999B 0.00
Sana Biotechnology (SANA) United States $0.970B 0.00
Applied Therapeutics (APLT) United States $0.964B 0.00
AnaptysBio (ANAB) United States $0.960B 0.00
Cullinan Therapeutics (CGEM) United States $0.956B 0.00
Prothena (PRTA) Ireland $0.897B 0.00
Immatics (IMTX) Germany $0.891B 0.00
Zymeworks (ZYME) United States $0.880B 0.00
IGM Biosciences (IGMS) United States $0.854B 0.00
MiMedx (MDXG) United States $0.851B 24.17
Replimune (REPL) United States $0.838B 0.00
CARGO Therapeutics (CRGX) United States $0.828B 0.00
Dianthus Therapeutics (DNTH) United States $0.822B 0.00
Immunome (IMNM) United States $0.811B 0.00
ArriVent BioPharma (AVBP) United States $0.799B 0.00
Castle Biosciences (CSTL) United States $0.786B 0.00
Liquidia Technologies (LQDA) United States $0.768B 0.00
Adaptive Biotechnologies (ADPT) United States $0.758B 0.00
Tango Therapeutics (TNGX) United States $0.754B 0.00
MBX Biosciences (MBX) $0.750B 0.00
Zenas BioPharma (ZBIO) $0.737B 0.00
Arbutus Biopharma (ABUS) United States $0.736B 0.00
AbCellera Biologics (ABCL) Canada $0.731B 0.00
89BIO (ETNB) United States $0.714B 0.00
Erasca (ERAS) United States $0.712B 0.00
Oric Pharmaceuticals (ORIC) United States $0.691B 0.00
Olema Pharmaceuticals (OLMA) United States $0.690B 0.00
Cytek Biosciences (CTKB) United States $0.689B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.686B 0.00
Avid Bioservices (CDMO) United States $0.685B 0.00
Rapport Therapeutics (RAPP) United States $0.682B 0.00
Humacyte (HUMA) United States $0.679B 0.00
Annexon (ANNX) United States $0.678B 0.00
CureVac (CVAC) Germany $0.672B 0.00
Pliant Therapeutics (PLRX) United States $0.663B 0.00
Abivax SA (ABVX) France $0.657B 0.00
Astria Therapeutics (ATXS) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.642B 0.00
Mineralys Therapeutics (MLYS) United States $0.637B 0.00
LENZ Therapeutics (LENZ) United States $0.629B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.628B 0.00
Entrada Therapeutics (TRDA) United States $0.606B 5.50
Scholar Rock Holding (SRRK) United States $0.588B 0.00
Terns Pharmaceuticals (TERN) United States $0.577B 0.00
Nuvation Bio (NUVB) United States $0.551B 0.00
Pharming Group (PHAR) Netherlands $0.549B 0.00
Revance Therapeutics (RVNC) United States $0.544B 0.00
Celcuity (CELC) United States $0.543B 0.00
Neurogene (NGNE) United States $0.542B 0.00
Allogene Therapeutics (ALLO) United States $0.529B 0.00
Third Harmonic Bio (THRD) United States $0.518B 0.00
Q32 Bio (QTTB) United States $0.509B 0.00
ACELYRIN, INC (SLRN) United States $0.508B 0.00
Oculis Holding AG (OCS) Switzerland $0.494B 0.00
Alumis (ALMS) United States $0.491B 0.00
REGENXBIO (RGNX) United States $0.490B 0.00
Emergent Biosolutions (EBS) United States $0.486B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.483B 0.00
Anavex Life Sciences (AVXL) United States $0.480B 0.00
CorMedix Inc (CRMD) United States $0.462B 0.00
PureTech Health (PRTC) United States $0.462B 0.00
Foghorn Therapeutics (FHTX) United States $0.461B 0.00
Contineum Therapeutics (CTNM) United States $0.458B 0.00
Tectonic Therapeutic (TECX) United States $0.442B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.439B 0.00
Alector (ALEC) United States $0.438B 0.00
Aura Biosciences (AURA) United States $0.434B 0.00
Absci (ABSI) United States $0.432B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.428B 0.00
Prime Medicine (PRME) United States $0.412B 0.00
GRAIL (GRAL) United States $0.411B 0.00
Northwest Biotherapeutics (NWBO) United States $0.407B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.400B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.396B 0.00
MaxCyte (MXCT) United States $0.393B 0.00
Cartesian Therapeutics (RNAC) United States $0.385B 0.00
Artiva Biotherapeutics (ARTV) United States $0.382B 0.00
Instil Bio (TIL) United States $0.377B 0.00
C4 Therapeutics (CCCC) United States $0.377B 0.00
Anika Therapeutics (ANIK) United States $0.370B 178.71
Biomea Fusion (BMEA) United States $0.367B 0.00
Fate Therapeutics (FATE) United States $0.366B 0.00
ITeos Therapeutics (ITOS) United States $0.359B 0.00
AC Immune (ACIU) Switzerland $0.344B 0.00
Nautilus Biotechnology (NAUT) United States $0.342B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.331B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.330B 0.00
GH Research (GHRS) Ireland $0.329B 0.00
XOMA Royalty (XOMA) United States $0.320B 0.00
Voyager Therapeutics (VYGR) United States $0.317B 20.79
Inozyme Pharma (INZY) United States $0.316B 0.00
Kamada (KMDA) Israel $0.301B 19.37
Urogen Pharma (URGN) United States $0.295B 0.00
PepGen (PEPG) United States $0.295B 0.00
Nkarta (NKTX) United States $0.294B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.294B 0.00
Sutro Biopharma (STRO) United States $0.288B 0.00
EnGene Holdings (ENGN) Canada $0.286B 0.00
Atea Pharmaceuticals (AVIR) United States $0.285B 0.00
Design Therapeutics (DSGN) United States $0.281B 0.00
Ocugen (OCGN) United States $0.279B 0.00
TScan Therapeutics (TCRX) United States $0.278B 0.00
MeiraGTx Holdings (MGTX) United States $0.275B 0.00
Alto Neuroscience (ANRO) United States $0.270B 0.00
Abeona Therapeutics (ABEO) United States $0.270B 0.00
Opthea (OPT) Australia $0.269B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.268B 0.00
Zura Bio (ZURA) United States $0.267B 0.00
Editas Medicine (EDIT) United States $0.266B 0.00
Compass Therapeutics (CMPX) United States $0.264B 0.00
ChromaDex (CDXC) United States $0.263B 0.00
Rezolute (RZLT) United States $0.261B 0.00
GENFIT S.A (GNFT) France $0.257B 0.00
Jasper Therapeutics (JSPR) United States $0.257B 0.00
Poseida Therapeutics (PSTX) United States $0.256B 0.00
Solid Biosciences (SLDB) United States $0.256B 0.00
Alpha Teknova (TKNO) United States $0.255B 0.00
Prima BioMed (IMMP) Australia $0.251B 0.00
Mersana Therapeutics (MRSN) United States $0.250B 0.00
Amarin (AMRN) Ireland $0.248B 0.00
2seventy Bio (TSVT) United States $0.248B 0.00
Precigen (PGEN) United States $0.244B 0.00
Fulcrum Therapeutics (FULC) United States $0.241B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.238B 0.00
Gossamer Bio (GOSS) United States $0.238B 0.00
Trevi Therapeutics (TRVI) United States $0.232B 0.00
XBiotech (XBIT) United States $0.228B 0.00
Cabaletta Bio (CABA) United States $0.225B 0.00
Black Diamond Therapeutics (BDTX) United States $0.225B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.224B 0.00
Inhibrx Biosciences (INBX) United States $0.223B 0.00
UniQure (QURE) Netherlands $0.221B 0.00
Codexis (CDXS) United States $0.219B 0.00
Candel Therapeutics (CADL) United States $0.219B 0.00
ScPharmaceuticals (SCPH) United States $0.218B 0.00
Kyverna Therapeutics (KYTX) United States $0.204B 0.00
23andMe Holding (ME) United States $0.190B 0.00
DiaMedica Therapeutics (DMAC) United States $0.190B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.187B 0.00
Greenwich LifeSciences (GLSI) United States $0.184B 0.00
Innate Pharma S.A (IPHA) France $0.176B 0.00
Compugen (CGEN) Israel $0.172B 0.00
Sangamo Therapeutics (SGMO) United States $0.170B 0.00
Molecular Partners AG (MOLN) Switzerland $0.170B 0.00
Scilex Holding (SCLX) United States $0.168B 0.00
Generation Bio (GBIO) United States $0.168B 0.00
Caribou Biosciences (CRBU) United States $0.161B 0.00
BioStem Technologies (BSEM) $0.159B 24.90
Seres Therapeutics (MCRB) United States $0.154B 0.00
Lifecore Biomedical (LFCR) United States $0.154B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.154B 0.00
Eton Pharmaceuticals (ETON) United States $0.153B 0.00
PDS Biotechnology (PDSB) United States $0.151B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.150B 0.00
Ventyx Biosciences (VTYX) United States $0.149B 0.00
Inovio Pharmaceuticals (INO) United States $0.147B 0.00
Repare Therapeutics (RPTX) Canada $0.146B 0.00
Immunic (IMUX) United States $0.143B 0.00
Adverum Biotechnologies (ADVM) United States $0.142B 0.00
Tenaya Therapeutics (TNYA) United States $0.140B 0.00
Actuate Therapeutics (ACTU) United States $0.139B 0.00
Kodiak Sciences (KOD) United States $0.138B 0.00
ATyr Pharma (ATYR) United States $0.135B 0.00
Vigil Neuroscience (VIGL) United States $0.135B 0.00
Akoya Biosciences (AKYA) United States $0.133B 0.00
Elutia (ELUT) United States $0.130B 0.00
Adherex Technologies (FENC) United States $0.127B 115.50
Oncobiologics (OTLK) United States $0.124B 0.00
Adicet Bio (ACET) United States $0.123B 0.00
Puma Biotechnology (PBYI) United States $0.121B 12.95
Cardiff Oncology (CRDF) United States $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.119B 0.00
I-Mab (IMAB) China $0.119B 0.00
Rani Therapeutics Holdings (RANI) United States $0.118B 0.00
Coherus BioSciences (CHRS) United States $0.118B 0.00
Verastem (VSTM) United States $0.117B 0.00
Seer (SEER) United States $0.117B 0.00
Invivyd (IVVD) United States $0.113B 0.00
Annovis Bio (ANVS) United States $0.109B 0.00
Cellectis S.A (CLLS) France $0.109B 0.00
Skye Bioscience (SKYE) United States $0.108B 0.00
Benitec Biopharma (BNTC) United States $0.108B 0.00
INmune Bio (INMB) United States $0.105B 0.00
Agenus (AGEN) United States $0.105B 0.00
Sagimet Biosciences (SGMT) United States $0.104B 0.00
Adagene (ADAG) China $0.104B 0.00
X4 Pharmaceuticals (XFOR) United States $0.103B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.102B 0.00
Checkpoint Therapeutics (CKPT) United States $0.101B 0.00
BeyondSpring (BYSI) United States $0.100B 0.00
Coya Therapeutics (COYA) United States $0.100B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.100B 0.00
Inventiva S.A (IVA) France $0.099B 0.00
BioAtla (BCAB) United States $0.098B 0.00
MediciNova (MNOV) United States $0.098B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.097B 0.00
ALX Oncology Holdings (ALXO) United States $0.096B 0.00
Bluebird Bio (BLUE) United States $0.094B 0.00
FibroBiologics (FBLG) United States $0.094B 0.00
BioHarvest Sciences (CNVCF) Canada $0.092B 0.00
InflaRx (IFRX) Germany $0.090B 0.00
CytomX Therapeutics (CTMX) United States $0.090B 8.21
HilleVax (HLVX) United States $0.090B 0.00
Werewolf Therapeutics (HOWL) United States $0.088B 0.00
CervoMed (CRVO) United States $0.084B 0.00
Chimerix (CMRX) United States $0.084B 0.00
Genenta Science S.p.A (GNTA) Italy $0.081B 0.00
VistaGen Therapeutics (VTGN) United States $0.081B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
Connect Biopharma Holdings (CNTB) United States $0.080B 0.00
Ovid Therapeutics (OVID) United States $0.080B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.080B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Genelux (GNLX) United States $0.079B 0.00
Rapt Therapeutics (RAPT) United States $0.079B 0.00
Cidara Therapeutics (CDTX) United States $0.074B 0.00
Adlai Nortye (ANL) Cayman Islands $0.073B 0.00
Aileron Therapeutics (ALRN) United States $0.072B 0.00
Immuneering (IMRX) United States $0.072B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.072B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.20
Boundless Bio (BOLD) United States $0.069B 0.00
IO Biotech (IOBT) Denmark $0.069B 0.00
Renovaro (RENB) United States $0.068B 0.00
Entera Bio (ENTX) Israel $0.066B 0.00
Precision BioSciences (DTIL) United States $0.066B 0.00
Oncolytics Biotech (ONCY) Canada $0.066B 0.00
DBV Technologies S.A (DBVT) France $0.064B 0.00
LakeShore Biopharma (LSB) China $0.063B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Leap Therapeutics (LPTX) United States $0.063B 0.00
TELA Bio (TELA) United States $0.061B 0.00
Kezar Life Sciences (KZR) United States $0.061B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
Omega Therapeutics (OMGA) United States $0.060B 0.00
Imunon (IMNN) United States $0.060B 0.00
Aerovate Therapeutics (AVTE) United States $0.060B 0.00
Shattuck Labs (STTK) United States $0.060B 0.00
Celularity (CELU) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Allakos (ALLK) United States $0.057B 0.00
Theratechnologies (THTX) Canada $0.055B 0.00
Earth Science Tech (ETST) United States $0.055B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.054B 0.00
Semper Paratus Acquisition (TVGN) United States $0.052B 0.00
Lexaria Bioscience (LEXX) Canada $0.052B 0.00
Syros Pharmaceuticals (SYRS) United States $0.052B 0.00
Intensity Therapeutics (INTS) United States $0.052B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.051B 0.00
Affimed (AFMD) Germany $0.050B 0.00
HOOKIPA Pharma (HOOK) United States $0.049B 0.00
Aadi Bioscience (AADI) United States $0.048B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.047B 0.00
CalciMedica (CALC) United States $0.046B 0.00
Rallybio (RLYB) United States $0.045B 0.00
Vor Biopharma (VOR) $0.045B 0.00
Estrella Immunopharma (ESLA) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Passage Bio (PASG) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Immix Biopharma (IMMX) United States $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.038B 0.00
Atara Biotherapeutics (ATRA) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Bionano Genomics (BNGO) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Fortress Biotech (FBIO) United States $0.036B 0.00
Cue Biopharma (CUE) United States $0.036B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.035B 0.00
Ocuphire Pharma (OCUP) United States $0.035B 0.00
Elevation Oncology (ELEV) United States $0.034B 0.00
OKYO Pharma (OKYO) $0.034B 0.00
Quince Therapeutics (QNCX) United States $0.034B 0.00
Clene (CLNN) United States $0.034B 0.00
Xilio Therapeutics (XLO) United States $0.033B 0.00
Ocean Biomedical (OCEA) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
BRIACELL THERAP (BCTX) Canada $0.031B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Curis (CRIS) United States $0.031B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Equillium (EQ) United States $0.030B 0.00
Lumos Pharma (LUMO) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Pluri (PLUR) Israel $0.029B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Aligos Therapeutics (ALGS) United States $0.027B 0.00
Longeveron (LGVN) United States $0.026B 0.00
BioAffinity Technologies (BIAF) United States $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
KALA BIO (KALA) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Gritstone Bio (GRTS) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
BioXcel Therapeutics (BTAI) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Orgenesis (ORGS) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.019B 0.00
Biora Therapeutics (BIOR) United States $0.018B 0.00
HCW Biologics (HCWB) United States $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.017B 0.00
Monopar Therapeutics (MNPR) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Cara Therapeutics (CARA) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.015B 0.00
Apollomics (APLM) United States $0.015B 0.00
Aprea Therapeutics (APRE) United States $0.015B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.014B 0.00
NKGen Biotech (NKGN) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Cadrenal Therapeutics (CVKD) United States $0.013B 0.00
Galecto (GLTO) Denmark $0.012B 0.00
IN8bio (INAB) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Evogene (EVGN) Israel $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Tenax Therapeutics (TENX) United States $0.011B 0.00
Soligenix (SNGX) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Kintara Therapeutics (KTRA) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Aptose Biosciences (APTO) Canada $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Carmell (CTCX) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.005B 0.00
Quantum Biopharma (QNTM) Canada $0.005B 0.00
Vaccinex (VCNX) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Trevena (TRVN) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Bionomics (BNOX) Australia $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Elevai Labs (ELAB) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00